Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smith Jason Drew Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2023 4 Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 409 shares @ $10.12, valued at $4.1k
Sold 1,227 shares @ $10.12, valued at $12.4k
Exercised 833 restricted stock units @ $0
Exercised 2,500 restricted stock units @ $0
Granted 20,000 restricted stock units @ $0
Granted 40,000 options to buy @ $10.39, valued at $415.6k
09/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 414 shares @ $7.58, valued at $3.1k
Exercised 833 restricted stock units @ $0
Granted 7,500 restricted stock units @ $0
Granted 30,000 options to buy @ $7.72, valued at $231.6k
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2020 4/A Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 60,000 options to buy @ $19.66, valued at $1.2M
Granted 25,000 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy